GBV-C/HGV infection in chronic hepatitis C patients: Its effect on clinical features and interferon therapy

Journal of Medical Virology

Volumn 55, Issue 2, 1998, Pages 98-102

  Oshita, Masahide ^a,b   Hayashi, Norio ^a   Mita, Eiji ^a   Iio, Sadaharu ^a   Hiramatsu, Naoki ^a   Hijioka, Taizo ^c   Kato, Michio ^d   Masuzawa, Manabu ^b,d   Sasaki, Yutaka ^a   Kasahara, Akinori ^a,e   Hori, Masatsugu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

^c MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^d Osaka National Science Institute   (Japan)

^e OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Coinfection; GBV C HGV; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON; LYMPHOBLAST INTERFERON; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; FEMALE; FLAVIVIRIDAE; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; RNA, VIRAL;

GB VIRUS C/HEPATITIS G VIRUS; HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031947253     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199806)55:2<98::AID-JMV3>3.0.CO;2-I     Document Type: Article

References (25)

1. Aikawa T, Sugai Y, Okamoto H (1996): Hepatitis G infection in drug abusers with chronic hepatitis C. The New England Journal of Medicine 334:195-196.
2. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, Lake JR, Roberts JR, Ascher NL, Ferrell L, Wright TL (1996): Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 111:1569-1575.
3. Bralet MP, Roudot-Thoraval F, Pawlotsky JM, Bastie A, Tran van Nhieu J, Duval J, Dhumeaux D, Zafrani ES (1997): Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 112:188-192.
4. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschieritz C, Ortego TJ, Gibas A, Hepatitis Interventional Therapy Group (1989): Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. The New England Journal of Medicine 321:1501-1506.
5. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH (1989): Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. The New England Journal of Medicine 321:1506-1510.
6. Fong TL, Di Bisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH (1991): The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 14:64-67.
7. Hagiwara H, Hayashi N, Mita E, Ueda K, Takehara T, Kasahara A, Fusamoto H, Kamada T (1992): Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha. Hepatology 15:37-41.
8. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, Mushahwar IK, Hunsmann G, Manns MP (1996): Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 348:1626-1629.
9. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollmam J (1981): Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435.
10. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, Schlauder GG, Dawson GJ, Desai SM, Mushahwar IK (1996): Sequence and genomic organization of GBV-C: A novel member of the Flaviviridae associated with human non-A-E hepatitis. Journal of Medical Virology 48:60-67.
11. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayiannis P, Fung K, Nakatsuji Y, Shih JW, Young L, Piatak M Jr, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Kim JP (1996): Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 271:505-508.
12. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, Murayama N, Inoue T, Tsuda F, Okamoto H, Miyazawa Y, Mayumi M (1996): Infection with hepatitis GB virus C in patients on maintenance hemodialysis. The New England Journal of Medicine 334:1485-1490.
13. Mita E, Hayashi N, Hagiwara H, Ueda K, Kanazawa Y, Kasahara A, Fusamoto H, Kamada T (1994): Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Digestive Diseases and Sciences 39:977-982.
14. Ohkawa K, Hayashi N, Yuki N, Hagiwara H, Kato M, Yamamoto K, Eguchi H, Fusamoto H, Masuzawa M, Kamada T (1994): Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. Journal of Hepatology 21:509-514.
15. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, Hosotsubo H, Deguchi M, Katayama K, Kasahara A, Fusamoto H, Kamada T (1995): Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. Journal of Medical Virology 46:258-264.
16. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A (1993): Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105: 1529-1533.
17. Roth WK, Lee JH, Ruster B, Zeuzem S (1996): Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. Journal of Clinical Microbiology 34:261-264.
18. Sheen IS, Liaw YF, Chu CM, Pao CC (1992): Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. Journal of Infectious Disease 165:831-834.
19. Sherlock S, Dooley J (1993): Viral hepatitis. In Sherlock S, Dooley J (eds): "Disease of the Liver and Biliary System." Oxford: Blackwell Scientific Publications, pp 260-292.
20. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS (1994): A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
21. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK (1995): Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1:564-569.
22. Weltman MD, Brotodihardjo A, Crewe EB, Farrell GC, Bilous M, Grierson JM, Liddle C (1995): Coinfection with hepatitis B, and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. Journal of Viral Hepatitis. 2:39-45.
23. Yoshiba M, Okamoto H, Mishiro S (1995): Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 346:1131-1132.
24. Yuki N, Hayashi N, Kasahara A, Hagiwara H, Katayama K, Fusamoto H, Kamada T (1992): Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Digestive Diseases and Sciences 37:65-72.
25. Zuckerman AJ (1996): Alphabet of hepatitis viruses. Lancet 347:558-559.